bupivacaine and 6,7-dihydroxyflavone

bupivacaine has been researched along with 6,7-dihydroxyflavone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ji, G; Li, B; Lu, K; Ma, H; Wang, J; Yang, F; Yu, J; Zhang, H; Zhang, Y; Zhao, L	1

Other Studies

1 other study(ies) available for bupivacaine and 6,7-dihydroxyflavone

Article	Year
Bupivacaine reduces GlyT1 expression by potentiating the p-AMPKα/BDNF signalling pathway in spinal astrocytes of rats. Scientific reports, 2022, 01-26, Volume: 12, Issue:1 Topics: AMP-Activated Protein Kinases; Anesthetics, Local; Animals; Animals, Newborn; Astrocytes; Brain-Derived Neurotrophic Factor; Bupivacaine; Cells, Cultured; Flavones; Gene Knockdown Techniques; Glycine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptor, trkB; Signal Transduction; Spinal Cord; Transfection	2022

Article

Year

Bupivacaine reduces GlyT1 expression by potentiating the p-AMPKα/BDNF signalling pathway in spinal astrocytes of rats.

Scientific reports, 2022, 01-26, Volume: 12, Issue:1

Topics: AMP-Activated Protein Kinases; Anesthetics, Local; Animals; Animals, Newborn; Astrocytes; Brain-Derived Neurotrophic Factor; Bupivacaine; Cells, Cultured; Flavones; Gene Knockdown Techniques; Glycine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptor, trkB; Signal Transduction; Spinal Cord; Transfection

2022